Insight Guru Inc.

11/18/2026 | Press release | Distributed by Public on 11/18/2026 03:33

Should You Buy The Dip In Intuitive Surgical Stock

For questions about this article or underlying research, email [email protected].

Intuitive Surgical (ISRG) stock closed at $430.53 on November 17, 2026, 10.7% below its close of November 4. That slide is part of a hard year: the stock lost 21.7% over the twelve months to November 17, while the S&P 500 gained 10.3%. A drop like this tempts you to buy the maker of the da Vinci surgical systems at a lower price. So has buying Intuitive Surgical after a sharp fall usually paid off?

Buyers Of Intuitive Surgical's Past Falls Mostly Gained

More often than not, yes, though the record is mixed. Since 2010, Intuitive Surgical stock has closed more than 20% below its price of 30 trading days earlier on 10 occasions. Each was a sharper fall than this one. By that same test, the stock is now 6.4% above its price of 30 trading days ago. Nine of those falls are more than a year old. The shares were higher twelve months later after five of them. The median change across all nine was a gain of about 29%. The latest fall, on July 23, 2026, is too recent to judge over a full year.

Collecting that gain took patience. Across those nine falls, the median low was 9.0% below the close on the day of the fall. The median wait for the best price of the following year was 295 days, almost ten months. After the fall of January 21, 2022, the stock sank to 32.1% below that day's close and was about 4% lower a year later.

Time after a past dip Past dips with that much time after them Median ISRG price change
21 trading days 10 9.5%
63 trading days 10 12.5%
126 trading days 9 10.0%
252 trading days 9 29.0%
Dip date Fall to dip date (ISRG / SPY) 1 year later Best in that year (days to it) Worst in that year
2026-07-23 -22.2% / 0.0% - - -
2025-04-04 -23.7% / -16.0% 0% 31.3% (277 days) -4.9%
2022-09-26 -21.2% / -14.0% 55.0% 88.9% (295 days) -2.6%
2022-05-06 -20.0% / -9.0% 34.0% 35.7% (362 days) -18.6%
2022-01-21 -20.9% / -6.0% -4.0% 13.4% (70 days) -32.1%
2020-03-16 -27.8% / -25.0% 80.0% 102.5% (298 days) -9.0%
2014-05-14 -24.7% / 0.0% 35.0% 48.8% (341 days) -2.2%
2013-07-19 -22.6% / 5.0% -1.0% 37.7% (258 days) -10.3%
2013-03-15 -20.0% / 5.0% -7.0% 11.8% (84 days) -22.5%
2010-08-26 -20.2% / -4.0% 29.0% 54.4% (329 days) -7.6%
Median of 9 complete years - 29.0% 37.7% (295 days) -9.0%
A dip date is the first day on which ISRG was more than 20% below its price 30 trading days earlier, counted once per run of such days. Dips counted from 2010-01-01 to 2026-11-17. Fall to dip date: the price change over those 30 trading days, for ISRG and for SPY over the same days. 1 year later: the price change 252 trading days after the dip date. Best and worst: the highest and lowest price in those 252 trading days against the dip-date price, with the calendar days to the highest. - means 252 trading days have not yet passed.

Intuitive Surgical's Sales And Operating Margin Keep Rising

Intuitive Surgical's revenue reached $11.6 billion in the twelve months to September 30, 2026, up 20.5% from the twelve months before. Operating margin is the share of revenue left as operating profit. Intuitive Surgical's rose to 29.3% in the twelve months to September 2025, from 26.2% a year earlier. It rose again to 32.3% in the latest twelve months, against 18.9% for the S&P 500. The company carries no debt and turned 35.3% of its revenue into cash from operations over those twelve months.

Investors pay for that quality. The stock trades at 50.8 times its earnings over the past twelve months, against 22.0 times for the S&P 500.

The catch is that Intuitive Surgical is cutting prices. Management described two price moves on its October 20, 2026 earnings call. One is a set of instrument pricing actions. The other is a price cut in China driven by government policy. Together, they should lower da Vinci instrument and accessory revenue per procedure by about 3% to 5% once fully in place. That estimate holds the mix of procedures, products and regions constant. Management called the instrument pricing actions a deliberate choice to broaden adoption in high-volume benign (non-cancer) procedures, such as hernia repair.

What You Must Believe To Buy Intuitive Surgical

Buying now means believing that a record built on deeper falls also holds for this shallower one. You must also be ready to sit through a further slide, as buyers after past falls had to. And you must believe that more procedures will make up for lower prices per procedure. Meanwhile, you pay a far higher multiple of earnings than the market. The China cut was scheduled to start in November 2026, according to management. Longer-life instruments, part of the company's broader pricing actions, are due to roll out country by country from the first half of 2027.

When Intuitive Surgical reports again, expected in January 2027, the number to watch is da Vinci instrument and accessory revenue per procedure. That figure was about $1,860 in the third quarter, against $1,800 a year earlier.

If you would rather see that report before you decide, the cash you are holding back can keep earning something while you wait.

Waiting To Buy Intuitive Surgical? Why Let Your Cash Sit Idle?

The right price can take months. Meanwhile, the Trefis Income Solution pays a dividend yield about 3x the S&P 500's, from 50 stocks with at least 10 straight years of dividends. Why not choose a better approach?

See If It Fits Your Plan

Spot an error or want more like this? Tell us in 10 seconds.

Insight Guru Inc. published this content on November 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 18, 2026 at 09:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]